Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04579692 · ClinicalTrials.gov registry record · NA
MR Guided Focused Ultrasound (FUS) for the Treatment of Trigeminal Neuralgia
A NA study of Trigeminal Neuralgia, sponsored by University of Maryland, Baltimore.
- Active
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT04579692: Active NA study of Trigeminal Neuralgia, sponsored by University of Maryland, Baltimore.
NCT04579692 is a NA study of Trigeminal Neuralgia that is active but no longer recruiting, run by University of Maryland, Baltimore. The registered enrollment target is 10 participants, below the 5,769-participant average among 9 other Trigeminal Neuralgia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04579692, a NA study of Trigeminal Neuralgia, is active but no longer recruiting, sponsored by University of Maryland, Baltimore.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the safety and effectiveness of MRI-guided focused ultrasound (MRgFUS) for treating Trigeminal Neuralgia. Trigeminal Neuralgia (pain) is a type of pain involving the face that can be disabling to those it affects.
Primary Outcome
Procedure related or device related adverse events will be reported, from the treatment day through the 6-month follow-up period.
Conditions Studied
Interventions
- DEVICE ExAblate Transcranial treatment
Study Locations (1)
Maryland
- University of Maryland Medical Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-08-16 |
| Est. Completion | 2026-05-28 |
| Phase | NA |
What the registry record for NCT04579692 still lists
NCT04579692 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 5,769-participant average among 9 other Trigeminal Neuralgia trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Trigeminal Neuralgia appearing as the primary indexed condition, and to 1 intervention - of which ExAblate Transcranial treatment is the first listed.
NCT04579692 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT04579692 about?
NCT04579692 is a clinical study titled "MR Guided Focused Ultrasound (FUS) for the Treatment of Trigeminal Neuralgia". The purpose of this study is to assess the safety and effectiveness of MRI-guided focused ultrasound (MRgFUS) for treating Trigeminal Neuralgia. Trigeminal Neuralgia (pain) is a type of pain involving the face that can be disabling to those it affects.
What is the current status of trial NCT04579692?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2021-08-16. Estimated completion is 2026-05-28.
What conditions does trial NCT04579692 study?
This clinical trial studies the following conditions: Trigeminal Neuralgia.
What interventions are being tested in trial NCT04579692?
The interventions under investigation include: ExAblate Transcranial treatment (DEVICE).
Who is sponsoring clinical trial NCT04579692?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04579692 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trigeminal Neuralgia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04579692's enrollment target sits among peer trials
10 10th of 9 the lowest of 9 other Trigeminal Neuralgia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Trigeminal Neuralgia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
RAD 1501: A Trial of Virtual Cone Trigeminal Neuralgia Radiosurgery
ACTIVE NOT RECRUITING · NA
-
Transcranial Magnetic Stimulation for Chronic Neuropathic Pain
ACTIVE NOT RECRUITING · NA
-
The Will Erwin Headache Research Center - Cluster Headache Study
RECRUITING
-
OnabotulinumtoxinA for Trigeminal Neuralgia
RECRUITING · Phase 4
-
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
RECRUITING
-
Trigeminal Evoked Responses to Improve Rhizotomy
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI